Trials / Completed
CompletedNCT00570440
Continuous Use of COCs
Continuous Versus Cyclic Use of Combined Oral Contraceptive Pills
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 362 (estimated)
- Sponsor
- FHI 360 · Academic / Other
- Sex
- Female
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
The primary objective is to determine if continuous COC use leads to higher continuation rates over 12 months of follow up than use of the standard 28-day COC regimen.
Detailed description
Family Health International has recently initiated a USAID funded study to investigate the pregnancy rates, continuation rates, and acceptability of COCs in women taking COCs by the 21/7 cyclic regimen compared with the continuous use of COCs with bleeding-signaled hormone-free intervals. The primary objective is to determine whether continuous COC use leads to higher 12-month continuation rates than use of the standard 28-day COC regimen. Secondary objectives are to 1) compare pregnancy probabilities through 6 and 12 months between the continuous use group and the 28-day group 2) compare COC continuation rates through 6 months between the continuous use group and the 28-day group 3) compare acceptability of the two COC regimens 4) to compare bleeding and other side effects between the continuous use group and the 28-day group 5) to compare hemoglobin/hematocrit between the continuous use group and the 28-day group
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oral contraceptives--ethinyl estradiol, levonorgestrel | 3 visits - screening/enrollment, 6-months and 12 months |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2007-12-11
- Last updated
- 2011-10-31
Locations
2 sites across 2 countries: Dominican Republic, Nicaragua
Source: ClinicalTrials.gov record NCT00570440. Inclusion in this directory is not an endorsement.